Latest Tegal Corp (CLRX) Headlines CollabRx Appoints

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Latest Tegal Corp (CLRX) Headlines

CollabRx Appoints Clifford Baron as Chief Operating Officer
GlobeNewswire - Wed Mar 05, 8:01AM CST
CollabRx, Inc. (Nasdaq:CLRX) today announced the appointment of Clifford Baron, PhD as Vice President and Chief Operating Officer. Mr. Baron's most recent position was with Accelrys, Inc. a $160M+ global software provider serving pharmaceutical, biotechnology, chemical, and materials corporations.

Taglich Brothers Initiates Coverage on CollabRx, Inc.
Marketwire - Mon Mar 03, 9:01AM CST
Taglich Brothers, Inc. announces it initiated coverage of CollabRx, Inc.

10-Q: COLLABRX, INC.
Edgar Online - Thu Feb 13, 1:06PM CST
Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations - (Amounts in thousands)

CollabRx Reports Third Quarter Fiscal Year 2014 Financial Results
GlobeNewswire - Tue Feb 11, 3:01PM CST
CollabRx, Inc. (the "Company") (Nasdaq:CLRX) today announced financial results for the third quarter of fiscal year 2014, which ended December 31, 2013.

CollabRx, Inc. Schedules Third Quarter Fiscal Year 2014 Financial Conference Call and Business Update
GlobeNewswire - Fri Jan 31, 8:01AM CST
CollabRx, Inc. (Nasdaq:CLRX), a data analytics company focused on genomics, today announced that it will hold an investor conference call on February 11, 2014 to discuss the Company's financial results for the third quarter of fiscal 2014 and to provide an update about the business in the current fiscal year.

CollabRx and CellNetix Partner to Advance Molecular Testing in Oncology
M2 - Tue Jan 28, 9:37AM CST
CollabRx, Inc. (NASDAQ: CLRX) and CellNetix Pathology & Laboratories, LLC, have announced a multi-year agreement to access CollabRx technology and content resources in support of the clinical interpretation of genetic sequencing-based tests provided by CellNetix.

CollabRx to Present at the Sixth Annual Personalized Medicine World Conference
GlobeNewswire - Tue Jan 21, 8:01AM CST
CollabRx, Inc. (Nasdaq:CLRX), a data analytics company focused on informing clinical decision making in molecular medicine, announces that Gavin J. Gordon, MBA, PhD, Vice President of Business Development & Strategic Alliances, will present in Track 2 (Big Data: Storage and Management) at the Personalized Medicine World Conference (PMWC) at 2 PM (PST) on January 28, 2014. The PMWC will be held January 26-28 at the Computer History Museum, 1401 N. Shoreline Blvd, Mountain View, California. The PMWC will include presentations and panel discussions from over 100 industry leaders from around the world.

CollabRx Launches New Web App for Cynvenio's ClearID Breast Cancer Patients
GlobeNewswire - Wed Jan 15, 8:01AM CST
CollabRx, Inc. (Nasdaq:CLRX), a leading data analytics company, today announced that its newest Therapy Finder for breast cancer patients will be made available in connection with the Cynvenio ClearID(TM) Breast Cancer genomic blood test. This announcement extends the scope of a previously disclosed multi-year agreement which announced the pairing of the CollabRx Genetic Variant Annotation (GVA) Service(TM) with tumor mutation profiling from whole blood provided by Cynvenio.

Cynvenio and CollabRx Announce Partnership for Cancer Molecular Diagnostics
PRWeb - Wed Dec 11, 8:23AM CST
Cynvenio, a cancer diagnostics company focused on transforming cancer treatment and management through the genomic analysis of tumor cells in blood, today announced a multi-year agreement with CollabRx, Inc., a data analytics company focused on informing clinical decision making in molecular medicine, to offer clinical actionable reports built from CollabRx data and information services with Cynvenio genomic tests.

CollabRx and Cynvenio Partner in Molecular Diagnostics for Cancer
GlobeNewswire - Wed Dec 11, 8:01AM CST
CollabRx, Inc. (Nasdaq:CLRX), a data analytics company focused on informing clinical decision making in molecular medicine, and Cynvenio Biosystems, Inc., a cancer diagnostics company, today announced a multi-year agreement to access CollabRx technology and content resources in support of the clinical interpretation of genetic sequencing-based tests provided by Cynvenio. The combined molecular testing and medical informatics solution will enable a more personalized approach to disease management by physicians who incorporate the results of molecular diagnostic testing into patient treatment planning.

CollabRx to Present at the LD MICRO Sixth Annual Conference
GlobeNewswire - Wed Nov 20, 1:36PM CST
CollabRx, Inc. (Nasdaq:CLRX), a data analytics company focused on informing clinical decision making in molecular medicine, announces that Thomas R. Mika, Chief Executive Officer, will present at the LD MICRO Sixth Annual Conference at 11 a.m. (PST), Track 1, on December 3, 2013. The conference will be held December 3-5, 2013 at the Luxe Sunset Bel Air, 11461 Sunset Boulevard, Los Angeles, California. CollabRx management will be available during the day on December 3 for one-on-one meetings. Please contact LD MICRO to schedule a meeting.

CollabRx earnings show improvement over previous year Q2
M2 - Thu Nov 14, 6:09AM CST
CollabRx, Inc. (NASDAQ: CLRX) said its total operating revenue for the second quarter of fiscal 2014 was USD251,000, with the entire amount representing the company's commercialization of its content services and on-line media products.

CollabRx Reports Second Quarter Fiscal Year 2014 Financial Results
GlobeNewswire - Wed Nov 13, 3:02PM CST
CollabRx, Inc. (the "Company") (Nasdaq:CLRX) today announced financial results for the second quarter of fiscal year 2014, which ended September 30, 2013.

CollabRx Inc partners with Quest Diagnostics for clinical cancer genetic sequencing
M2 - Tue Nov 12, 10:37AM CST
Data analytics company CollabRx Inc (NasdaqCM:CLRX) reported on Monday the launch of a multi-year, non-exclusive agreement related to medical annotation for new next-generation sequencing test services for cancer.

CollabRx working with Quest Diagnostics in clinical genetic sequencing
M2 - Tue Nov 12, 7:42AM CST
CollabRx, Inc. (NASDAQ: CLRX) has announced a multi-year, non-exclusive agreement with Quest Diagnostics (NYSE: DGX), a provider of diagnostic information services related to medical annotation for new next-generation sequencing test services for cancer.

Nasdaq stocks posting largest volume increases
AP - Mon Nov 11, 5:11PM CST
NEW YORK (AP) — A look at the 10 biggest volume gainers on Nasdaq at the close of trading:

Nasdaq stocks posting largest percentage increases
AP - Mon Nov 11, 12:25PM CST
NEW YORK (AP) — A look at the 10 biggest percentage gainers on Nasdaq at 1 p.m.:

ZLCS, CLRX, DSCO and GALE added to NASDAQ Active Stock Watch List at GSR
ACCESSWIRE - Mon Nov 11, 9:19AM CST
New York, NY - (ACCESSWIRE) - 11/11/2013 - Growing Stock Report initiates its NASDAQ Active Stock Weekly Watch List adding Zalicus Inc. (NASDAQ:ZLCS), CollabRx, Inc. (NASDAQ:CLRX), Discovery Laboratories Inc. (NASDAQSCO) and Galena Biopharma, Inc. (NASDAQ:GALE).

CollabRx Teams With Quest Diagnostics in Clinical Genetic Sequencing
GlobeNewswire - Mon Nov 11, 6:01AM CST
CollabRx, Inc. (Nasdaq:CLRX), a data analytics company focused on informing clinical decision making in molecular medicine, today announced a multi-year, non-exclusive agreement with Quest Diagnostics (NYSEGX), the world's leading provider of diagnostic information services, related to medical annotation for new next-generation sequencing test services for cancer.

Rennova Health, Inc. (RNVA) Stock Research Links

RNVA Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Older Adults Embrace Cosmetic Dentistry for Confidence

Updated Category News Views 161

Why the Shift to Cosmetic Dentistry Later in Life? Aging doesn't just wrinkle your skin; it affects your smile too. Dr. Joseph T. Sumrall and Dr. Gran Sumrall, the dental gurus of Warner Robins, Georgia, are laying out why more adults are jumping on the cosmetic dentistry bandwagon as they age. Spoiler: It ain't about getting a movie-star grin but something much deeper....

Continue Reading
Copper Peptides Shine in New Renue Blue Cream

Updated Category News Views 127

Renue By Science's Ambitious Skincare Launch Alright, we've got a big player stepping up in the realm of skincare with a new face cream packed tightly with science-backed goodies. Renue By Science is revamping their game by anchoring their new Renue Blue Face Cream around the star of the moment: copper tripeptide-1, also known as GHK-Cu. This is more than a beauty gloss...

Continue Reading
Kinross Gold Fraud Lawsuit: What Shareholders Need to Know

Updated Category News Views 58

Kinross Gold's Legal Quagmire There's a fresh storm brewing for Kinross Gold Corporation (NYSE: KGC), and it ain't the kind investors enjoy riding. You see, the company is up to its neck in a class action lawsuit, courtesy of Schall, Brown & Schwartz LLP—a big-name shareholder rights litigation outfit. The gripe? Alleged securities fraud, violating §§10(b) and 20(a)...

Continue Reading
Choate's Expands to New Mid-South Markets

Updated Category News Views 118

Family Traditions Drive Choate's Growth Back in the day, you might've thought the family-run businesses were a dying breed, right? Not in the case of Choate's Air Conditioning, Heating, Plumbing & Electrical. These folks aren't just holding the fort; they're storming new territories across the Mid-South like they've got something to prove—or maybe just something to...

Continue Reading
Epic Legal Battle Yields $63M Verdict Against Chevron

Updated Category News Views 147

A David vs. Goliath Showdown in Court How's this for a courtroom drama? Picture eight lawyers taking on Chevron over a toxic pit buried beneath an unsuspecting family's home. These folks at Ernst Law Group and Trial Lawyers for Justice tackled Union Oil (now Chevron) and bagged a staggering $63 million for their client. This ain't your run-of-the-mill legal squabble; it's...

Continue Reading
SiteOne Joins S&P SmallCap 600 Amid KKR's Integer Buyout

Updated Category News Views 89

Changes on the SmallCap Horizon Starting off, SiteOne Landscape Supply (NYSE: SITE) is hopping onto the S&P SmallCap 600 bandwagon. This shift activates just as the market revs up on November 19, 2026. SiteOne is stepping in as Integer Holdings Corp. (NYSE: ITGR) makes its grand exit, a move prompted by a significant acquisition by KKR & Co. Inc. (NYSE: KKR). KKR’s...

Continue Reading
Halfday Iced Tea Shakes Up U.S. Retail Scene

Updated Category News Views 142

Halfday's Meteoric Rise in the U.S. Market Sometimes, you pick up a can of iced tea, and it just changes the game. That’s exactly what Halfday is doing, stepping on the accelerator and leaving traditional iced tea brands in the dust. With their latest announcement, they've snagged the title of the fastest-growing modern tea brand in U.S. multi-outlet retail. It's the...

Continue Reading
Sue Egstrand to Lead Karo's Next Growth Phase

Updated Category News Views 222

A New Captain at Karo’s Helm Karo Healthcare is bracing for an exciting ride. Sue Egstrand’s appointment as the new CEO pulls the curtain on what might just be a game-changing era for the company. Set to take the wheel on January 1, 2027, Egstrand brings a heavy-hitting resume—a mash-up of pharmaceutical prowess and a deep-dive into consumer healthcare. Sue’s...

Continue Reading
Nord Anglia Schools Shine with 13 Tes Awards Nominations

Updated Category News Views 154

Nord Anglia's Moment of Glory at Tes Awards You think you know the big players in the educational game? Well, guess again. Nord Anglia's come out swinging with a whopping 13 finalist nominations at the 2026 Tes Awards for International Schools. It ain't easy making waves in the education sector, but these folks are showing they've got what it takes to turn heads, not just...

Continue Reading
Trades Workforce Shortage Costs Wallop U.S. Economy

Updated Category News Views 113

The Forgotten Backbone of America Don't sleep on this: America's got itself a trade worker crisis, and it's not just a numerical hiccup. We’re down nearly 1.9 million skilled trades workers, and that's a gut punch to the economy—a hefty $1.2 billion a day in GDP loss. These are the folks who keep the wheels greased, the lights on, and the goods flowing. Without them,...

Continue Reading

Top 5 Most Recently Viewed Articles

Market Insights: S&P 500 Forecasted Decline and Job Growth Impact

Updated Category News Views 107

Market Insights on Economic Factors Impacting S&P 500 Recent reports have revealed that the job market in the United States is displaying significant strength. According to recent statistics, there was an addition of 256,000 jobs, which paints a picture of a robust economy. However, this strong job growth can bring mixed signals for investors regarding the stock market,...

Continue Reading
Safety Tech in Fleets: Drivers Embrace Its Role

Updated Category News Views 65

Drivers Warming Up to Fleet Safety Tech Seems like most fleet drivers these days are eyeing safety tech through a fresher lens. Gone are the days when grumbling about privacy was the anthem of the disgruntled. The latest Linxup survey claims a whopping 77% of commercial fleet pros have hopped onto the safety train, happily trading privacy qualms for the perks of solid...

Continue Reading
Celebrating 50 Years of Excellence at Amerijet Airlines

Updated Category News Views 200

Amerijet International Airlines: A Milestone Celebration Amerijet International Airlines proudly celebrates its 50th anniversary this year, marking five decades of dedication to air cargo services that connect diverse regions. Founded by David Bassett in 1974, the airline began its journey as a small Part 135 air-taxi operator, operating a single leased aircraft. Over the...

Continue Reading
Petit Pot Wins $100K Prize at 2024 Real California Milk Event

Updated Category News Views 195

Petit Pot Celebrates a Momentous Achievement in Dairy Innovation In an exciting showcase of dairy innovation, Petit Pot has emerged as the grand prize winner of the 2024 Real California Milk (RCM) Excelerator competition. This prestigious award highlights the company's commitment to producing high-quality dairy-based desserts and its remarkable sales achievements in a...

Continue Reading
Exploring the Affordability and Safety Debate in Autos

Updated Category News Views 295

Affordability Angst, and a Scapegoat Nobody Asked For Echoes of old policy fights come roaring back here—every time car prices spike, somebody points at safety rules like they’re the boogeyman under the bed (and, yeah, it kinda ticks me off). Lawmakers have been poking at features like Auto Emergency Braking, and the broader affordability debate has gotten tangled up...

Continue Reading